nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0526	0.0637	CcSEcCtD
Pirbuterol—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0504	0.0609	CcSEcCtD
Pirbuterol—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0424	0.0512	CcSEcCtD
Pirbuterol—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0348	0.042	CcSEcCtD
Pirbuterol—ADRB1—Endothelin Pathways—ADCY10—nephrolithiasis	0.034	0.196	CbGpPWpGaD
Pirbuterol—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0312	0.0377	CcSEcCtD
Pirbuterol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0285	0.0345	CcSEcCtD
Pirbuterol—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0249	0.0301	CcSEcCtD
Pirbuterol—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0218	0.0264	CcSEcCtD
Pirbuterol—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0203	0.0246	CcSEcCtD
Pirbuterol—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0194	0.0234	CcSEcCtD
Pirbuterol—Tension—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0226	CcSEcCtD
Pirbuterol—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0224	CcSEcCtD
Pirbuterol—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0223	CcSEcCtD
Pirbuterol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0183	0.0222	CcSEcCtD
Pirbuterol—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0216	CcSEcCtD
Pirbuterol—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0175	0.0212	CcSEcCtD
Pirbuterol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0207	CcSEcCtD
Pirbuterol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0204	CcSEcCtD
Pirbuterol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0203	CcSEcCtD
Pirbuterol—Cough—Hydrochlorothiazide—nephrolithiasis	0.0166	0.0201	CcSEcCtD
Pirbuterol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0196	CcSEcCtD
Pirbuterol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0196	CcSEcCtD
Pirbuterol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0192	CcSEcCtD
Pirbuterol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0157	0.019	CcSEcCtD
Pirbuterol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0188	CcSEcCtD
Pirbuterol—Shock—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0185	CcSEcCtD
Pirbuterol—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0184	CcSEcCtD
Pirbuterol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0179	CcSEcCtD
Pirbuterol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0176	CcSEcCtD
Pirbuterol—ADRB1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0141	0.0815	CbGpPWpGaD
Pirbuterol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0141	0.017	CcSEcCtD
Pirbuterol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0167	CcSEcCtD
Pirbuterol—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0138	0.0798	CbGpPWpGaD
Pirbuterol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0164	CcSEcCtD
Pirbuterol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0162	CcSEcCtD
Pirbuterol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0155	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0154	CcSEcCtD
Pirbuterol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0149	CcSEcCtD
Pirbuterol—ADRB1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0119	0.0685	CbGpPWpGaD
Pirbuterol—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0116	0.0671	CbGpPWpGaD
Pirbuterol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0135	CcSEcCtD
Pirbuterol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.011	0.0133	CcSEcCtD
Pirbuterol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0129	CcSEcCtD
Pirbuterol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0125	CcSEcCtD
Pirbuterol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0099	0.012	CcSEcCtD
Pirbuterol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00982	0.0119	CcSEcCtD
Pirbuterol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00981	0.0119	CcSEcCtD
Pirbuterol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00975	0.0118	CcSEcCtD
Pirbuterol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00925	0.0112	CcSEcCtD
Pirbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00865	0.05	CbGpPWpGaD
Pirbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00847	0.0489	CbGpPWpGaD
Pirbuterol—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.00613	0.0354	CbGpPWpGaD
Pirbuterol—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00448	0.0259	CbGpPWpGaD
Pirbuterol—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.00438	0.0253	CbGpPWpGaD
Pirbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00423	0.0244	CbGpPWpGaD
Pirbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00413	0.0239	CbGpPWpGaD
Pirbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00272	0.0157	CbGpPWpGaD
Pirbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00266	0.0154	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00233	0.0135	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00228	0.0132	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00206	0.0119	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00201	0.0116	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.00187	0.0108	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.00183	0.0106	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00178	0.0103	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00174	0.01	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.00163	0.00939	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.00159	0.00919	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00139	0.00803	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00136	0.00785	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.0013	0.0075	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.00127	0.00733	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.00126	0.00729	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.00123	0.00713	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.0011	0.00637	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.00108	0.00623	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.001	0.0058	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000983	0.00568	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.000919	0.00531	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000912	0.00527	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.000899	0.00519	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000892	0.00515	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.000834	0.00482	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.000816	0.00471	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.000745	0.00431	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000745	0.00431	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.000729	0.00421	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000729	0.00421	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.000539	0.00311	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000527	0.00304	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.000493	0.00285	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000482	0.00278	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	0.000247	0.00143	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	0.000242	0.0014	CbGpPWpGaD
